Search

Displaying results 4931 - 4940 of 7452 in total
  1. Drug

    Evexomostat

    go.drugbank.com/drugs/DB19140
    Investigational

    Evexomostat is under investigation in clinical trial NCT05570253 (A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer).

  2. Drug

    Oxymatrine

    go.drugbank.com/drugs/DB16276
    Investigational

    Oxymatrine is under investigation in clinical trial NCT02202473 (Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects).

  3. Drug

    Autogene cevumeran

    go.drugbank.com/drugs/DB17497
    Investigational

    It is being investigated for cancers.

  4. Drug

    Valomaciclovir stearate

    go.drugbank.com/drugs/DB15651
    Investigational

    Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster).

  5. Drug

    Melarsoprol

    go.drugbank.com/drugs/DB12864
    Investigational

    Melarsoprol is under investigation in clinical trial NCT00330148 (Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis).

  6. Drug

    ABT-751

    go.drugbank.com/drugs/DB12254
    Investigational

    ABT-751 has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.

  7. Drug

    Aklavine

    go.drugbank.com/drugs/DB19070
    Experimental

    Aklavine is under investigation in clinical trial NCT03026842 (Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With T(8;21)).

  8. Drug

    Pegvisomant

    go.drugbank.com/drugs/DB00082
    ApprovedInvestigational

    Unlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main

  9. Drug

    Sodium sulfide

    go.drugbank.com/drugs/DB11159
    Approved

    Along with its hydrate form, sodium sulfide releases hydrogen sulfide (H2S) when in contact with moist air. … Interestingly, sodium sulfide was shown to have some cardioprotective role against cardiac ischemia or reperfusion injury, as well as protect lungs against ventilator-induced lung injury [A27275].

  10. Drug

    INNO-305

    go.drugbank.com/drugs/DB06025
    Investigational

    INNO-305 is an investigational vaccine developed by Innovive Pharmaceuticals for the treatment of patients with acute myeloid leukemia in complete remission.